Lincoln Pharmaceuticals Ltd LINCOLN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- INR 567.45
- Day Range
- INR 565.90–574.60
- 52-Week Range
- INR 365.25–755.15
- Bid/Ask
- INR 568.00 / INR 568.25
- Market Cap
- INR 11.38 Bil
- Volume/Avg
- 29,856 / 84,069
Key Statistics
- Price/Earnings (Normalized)
- 14.93
- Price/Sales
- 1.96
- Dividend Yield (Trailing)
- 0.26%
- Dividend Yield (Forward)
- 0.26%
- Total Yield
- 0.26%
Company Profile
Lincoln Pharmaceuticals Ltd is an India-based company engaged in the business of manufacturing and trading of pharmaceutical products. It offers products in the fields of Cardiac, Diabetic, Anti-malarial, Anti-biotic, Anti-fungal, Cephalosporin, Analgesic, Anaesthetics, Anti-pyretic, GIT products, Vitamin-Minerals, and Iron preparations. Geographically, the company carries out sales in India and outside India; generating key revenue from outside India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,700
- Website
- https://www.lincolnpharma.com
Comparables
Valuation
|
Metric
|
LINCOLN
|
524348
|
543434
|
|---|---|---|---|
Price/Earnings (Normalized) | 14.93 | 26.75 | 24.46 |
Price/Book Value | 1.92 | 3.55 | 3.98 |
Price/Sales | 1.96 | 1.80 | 5.50 |
Price/Cash Flow | 14.56 | 20.24 | 27.93 |
Price/Earnings
LINCOLN
524348
543434
Financial Strength
|
Metric
|
LINCOLN
|
524348
|
543434
|
|---|---|---|---|
Quick Ratio | 3.83 | 0.91 | 3.14 |
Current Ratio | 4.84 | 1.66 | 6.26 |
Interest Coverage | 84.45 | 8.03 | 192.48 |
Quick Ratio
LINCOLN
524348
543434
Profitability
|
Metric
|
LINCOLN
|
524348
|
543434
|
|---|---|---|---|
Return on Assets (Normalized) | — | 7.10% | — |
Return on Equity (Normalized) | — | 13.89% | — |
Return on Invested Capital (Normalized) | — | 10.74% | — |
Return on Assets
LINCOLN
524348
543434
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Kphyrxclk | Jmvgk | $79.4 Bil | |
MKKGY
| Merck KGaA ADR | Lynhyqkc | Htpnw | $78.2 Bil | |
HLN
| Haleon PLC ADR | Qkzpsyfr | Rpjd | $38.4 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Zhngqbs | Mwl | $17.7 Bil | |
VTRS
| Viatris Inc | Yypzpvlj | Hlhm | $12.9 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Xxlhjwjwc | Yfb | $11.7 Bil | |
CTLT
| Catalent Inc | Wnmptstl | Zlywhg | $9.9 Bil | |
CURLF
| Curaleaf Holdings Inc | Yyjthcb | Vbw | $4.2 Bil | |
PRGO
| Perrigo Co PLC | Qhjsbsjk | Ywpfv | $4.0 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Tjsbgzs | Ffjbhjl | $3.2 Bil |